Good morning. If you’re just waking up, $AMRN is trading at $10. That a 200%-plus move. Grab some coffee and read

Posted in Biotech

September 24, 2018

The first generic version of EpiPen has been approved. FDA granted Teva clearance to sell a potentially cheaper autoinjector

Posted in Biotech

August 16, 2018

Mannkind is the MoviePass of biotech.

Posted in Biotech

August 03, 2018

GlaxoSmithKline is partnering with 23andMe to develop new medicines. The companies will split costs and profits equally, and Glaxo will make a $300 million investment in 23andMe

Posted in Biotech

July 25, 2018